Marc Lemaître

Link has appointed Marc Lemaître as chairman of the board. He takes over from Mick McLean, who is stepping down after nine years in the role. Lemaître currently works as an independent consultant, although he joined Link in 2015 as a non-executive director. He has also worked for Glen Research and served as CEO of Grindus America.


Keith Regnante

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.